Description
Product details
EPSTATE SR 150 Epalrestat Tablets ER (50mg) EPSTATE SR 150 features Epalrestat Tablets ER, an extended-release formulation specifically designed to manage and treat diabetic neuropathy. Each tablet contains 150 mg of Epalrestat, which effectively inhibits aldose reductase. This action is crucial in slowing the glucose conversion into sorbitol, a sugar alcohol that, when accumulated, contributes to nerve, eye, and kidney damage associated with diabetes. By managing this pathway, EPSTATE SR 150 helps alleviate symptoms such as pain, numbness, and tingling sensations in the limbs, thus enhancing the quality of life for diabetic patients. This medication is a step forward in preventive diabetic care, focusing on long-term nerve health.For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 Order Now: